Simvastatin in treatment of elderly efficacy of transient ischemic attack
Lin Zhong-r
Abstract
Lin Zhong-r
Abstract
Objective To study the short-term simvastatin treatment of elderly ischemic attack (TIA), efficacy, provide the basis for clinical treatment. Methods In May 2008~2010 hospital clinic in February of 98 cases over the age of 60 TIA patients were divided into treatment group and control group was given enteric-coated aspirin tablets in the treatment; the treatment group were treated with simvastatin tablets for 4 weeks to a course of treatment.Results After treatment, no seizures, the symptoms improved significantly fewer episodes were better than the control group, the two groups was statistically significant (P0.01).Conclusion Simvastatin treatment of elderly transient ischemic attack effect is significant, worthy of promotion.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Objective To study the short-term simvastatin treatment of elderly ischemic attack (TIA), efficacy, provide the basis for clinical treatment. Methods In May 2008~2010 hospital clinic in February of 98 cases over the age of 60 TIA patients were divided into treatment group and control group was given enteric-coated aspirin tablets in the treatment; the treatment group were treated with simvastatin tablets for 4 weeks to a course of treatment.Results After treatment, no seizures, the symptoms improved significantly fewer episodes were better than the control group, the two groups was statistically significant (P0.01).Conclusion Simvastatin treatment of elderly transient ischemic attack effect is significant, worthy of promotion.
Key concepts: Medicine, Simvastatin, Aspirin, Treatment and control groups, Clinical efficacy, Low dose aspirin, Internal medicine